Phaarmasia Limited (BOM:523620)
110.35
-2.25 (-2.00%)
At close: Jan 22, 2026
Phaarmasia Market Cap
Phaarmasia has a market cap or net worth of 753.36 million as of January 23, 2026. Its market cap has increased by 121.14% in one year.
Market Cap
753.36M
Enterprise Value
749.06M
Revenue
335.76M
Ranking
n/a
PE Ratio
96.07
Stock Price
110.35
Market Cap Chart
Since April 13, 1998, Phaarmasia's market cap has increased from 13.70M to 753.36M, an increase of 5,398.06%. That is a compound annual growth rate of 15.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 753.36M | -2.12% |
| Dec 31, 2025 | 769.67M | 132.45% |
| Dec 31, 2024 | 331.11M | 23.19% |
| Dec 29, 2023 | 268.78M | 41.36% |
| Dec 30, 2022 | 190.13M | -15.73% |
| Dec 31, 2021 | 225.63M | -8.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Godavari Drugs | 987.42M |
| Mercury Laboratories | 960.00M |
| Source Natural Foods and Herbal Supplements | 895.70M |
| Amwill Health Care | 851.15M |
| Zenith Drugs | 846.29M |
| Mangalam Drugs & Organics | 782.71M |
| Accretion Pharmaceuticals | 756.44M |
| Makers Laboratories | 723.39M |